Hydrochlorothiazide 15 MG Methyldopa 250 MG Oral Tablet
INDICATIONS AND USAGE Hypertension - (see box WARNING ).
Mylan Pharmaceuticals Inc.
ROUND GREEN MYLAN 507
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Methyldopa and Hydrochlorothiazide Tablets, USP are available containing 250 mg of methyldopa, USP (calculated as anhydrous) with 15 mg or 25 mg of hydrochlorothiazide, USP providing the following combinations: 250 mg/15 mg or 250 mg/25 mg. The 250 mg/15 mg tablets are green, film-coated, round, unscored tablets debossed with MYLAN on one side and 507 on the other side. They are available as follows: NDC 0378-0507-01 bottles of 100 tablets The 250 mg/25 mg tablets are green, film-coated, capsule-shaped, unscored tablets debossed with MYLAN on one side and 711 on the other side. They are available as follows: NDC 0378-0711-01 bottles of 100 tablets Store at 20º to 25ºC (68º to 77ºF). [See USP Controlled Room Temperature.] Protect from light. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Revised: 4/2020 MDHZ:R6AQ
More pills like ROUND MYLAN 507